Overview Fundamentals API Earnings EOD API Sample Code Pricing

BCAL Diagnostics Ltd (BDX AU) stock market data APIs

A$0.1175 -0(-0%) as of September 16, 2024
Price chart is built with Anychart

BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a non-invasive blood test for the detection of breast cancer. It develops BCAL test, a lipid biomarker blood test with the potential to be used for breast cancer prevention, screening, and monitoring; and in vitro diagnostic test (IVD) that confirms a fingerprint of lipid biomarkers extracted from patient's blood plasma to diagnose the presence of breast cancer cells in a patient's body. The company was incorporated in 2010 and is headquartered in Sydney, Australia.

BCAL Diagnostics Ltd Financial Data Overview

0.12
0.1175
-
0.12
0.115
0.085-0.185
41 146 K
358 M
3 098 K
-0.01
0.69
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BDX',
Type: 'Common Stock',
Name: 'BCAL Diagnostics Ltd',
Exchange: 'AU',
CurrencyCode: 'AUD',
CurrencyName: 'Australian Dollar',
CurrencySymbol: 'A$',
CountryName: 'Australia',
CountryISO: 'AU',
OpenFigi: 'BBG00CZTG7V4',
ISIN: 'AU0000160921',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

BCAL Diagnostics Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 098 K
  • EBITDA -5 666 812
  • Earnings Per Share -0.03
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BCAL Diagnostics Ltd Earnings via APIs

  • Latest Release 2023-02-23
  • EPS/Forecast 0

Get BCAL Diagnostics Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com